Moneycontrol
Get App
Last Updated : May 15, 2020 10:46 AM IST | Source: Moneycontrol.com

Explained | COVID-19: Gilead licensing agreement of Remdesivir

In this episode of the Explained series, understand what does the licensing agreements mean for the fight against COVID-19.


US-based Gilead Sciences announced non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers for its antiviral drug Remdesivir. While countries like the US and Japan have approved the use of the medicine, it is under consideration for treatment of COVID-19 patients in India.

In this episode of the Explained series, understand what does the licensing agreements mean for the fight against COVID-19.

Watch the video for more.

Close

 

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

First Published on May 15, 2020 10:46 am
Sections
Follow us on